Epidemiology of Esophageal Cancer

Surgical Clinics of North America

Volumn 92, Issue 5, 2012, Pages 1077-1087

  Wheeler, Jason B ^a   Reed, Carolyn E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Epidemiology adenocarcinoma of the esophagus; Epidemiology squamous cell carcinoma of the esophagus; Risk factors for esophageal cancer

Indexed keywords

AROMATIC HYDROCARBON; BETA CAROTENE; EPIDERMAL GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MOLYBDENUM; NITROSAMINE; NITROSO DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TOBACCO SMOKE;

AFRICA; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ALPHA TOCOPHEROL DEFICIENCY; ASIA; AUSTRALIA; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENIC ACTIVITY; CAUCASIAN; CHINA; DIETARY INTAKE; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; FRUIT; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HEREDITY; HISTOLOGY; HUMAN; HYPERKERATOSIS; INDIA; MINERAL DEFICIENCY; MULTIPLE ENDOCRINE NEOPLASIA; MYOTOMY; NORTH AMERICA; NUTRITIONAL DEFICIENCY; OBESITY; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RACE DIFFERENCE; RETINOL DEFICIENCY; REVIEW; RUSSIAN FEDERATION; SCLERODERMA; SELENIUM DEFICIENCY; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; SOUTHEAST ASIA; STOMACH ACID; STOMACH ACID SECRETION; TAIWAN; TYLOSIS; UNITED STATES; VEGETABLE; WESTERN EUROPE; ZENKER DIVERTICULUM; ZINC DEFICIENCY; ZOLLINGER ELLISON SYNDROME;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; RISK FACTORS; WORLD HEALTH;

EID: 84866874909     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.07.008     Document Type: Review

References (49)

1. Cancer Statistics, World Cancer Research Fund International. Available at: . Accessed August 12, 2012. http://www.werf.org/cancer_statistics/index/php.
2. Pohl H., Sirovich B., Welch H.G. Esophageal adenocarcinoma incidence: are we reaching the peak?. Cancer Epidemiol Biomarkers Prev 2010, 19:1468-1470.
3. Wei J.T., Shaheen N.J. The changing epidemiology of esophageal adenocarcinoma. Semin Gastrointest Dis 2003, 14:112-127.
4. Sampliner R.E., Gibson M.K. Epidemiology, pathobiology, and clinical manifestations of esophageal cancer 2011, Up To Date, Available at:, Accessed August 12, 2012. http://www.uptodate.com.
5. Holmes R.S., Vaughan T.L. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2006, 17:2-9.
6. Blot W.J., McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 1999, 26:2-8.
7. Tran G.D., Sun X.D., Abnet C.C., et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005, 113:456-463.
8. Lee C.H., Lee J.M., Wu D.C., et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 2005, 113:475-482.
9. Islami F., Boffetta P., Ren J.S., et al. High-temperature beverages and foods and esophageal cancer risk-a systematic review. Int J Cancer 2009, 125:491-524.
10. Lukanich J.M. Section I: epidemiologic review. Semin Thorac Cardiovasc Surg 2003, 15:158-166.
11. Chang-Claude J., Becher H., Blettner M., et al. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol 1997, 26:1159-1165.
12. Appelqvist P., Salmo M. Lye corrosion carcinomas of the esophagus: a review of 63 cases. Cancer 1980, 45:2655-2658.
13. Sandler R.S., Nyrén O., Ekbom A., et al. The risk of esophageal cancer in patients with achalasia: a population-based study. J Am Med Assoc 1995, 274:1359-1362.
14. Ribeiro U., Rosner M.C., Safatle-Ribeiro A.V., et al. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg 1996, 83:1174-1185.
15. Cooper J.S., Pajak T.F., Rubin P., et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989, 17:449-456.
16. Erkal H.S., Mendenhall W.M., Amdur R.J., et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 2001, 19:1358-1362.
17. Muto M., Hironaka S., Nakane M., et al. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002, 56:517-521.
18. Brown L.M., Devesa S.S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002, 11:235-256.
19. Jansson C., Plato N., Johansson A.L., et al. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma. Occup Environ Med 2006, 63:107-112.
20. Engel L.S., Vaughan T.L., Gammon M.D., et al. Occupation and risk of esophageal and gastric cardia adenocarcinoma. Am J Ind Med 2002, 42:11-22.
21. Engel L.S., Chow W.H., Vaughan T.L., et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003, 95:1404-1413.
22. El-Serag H.B., Mason A.C., Petersen N., et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002, 50:368-372.
23. Pera M., Manterola C., Vidal O., et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005, 92:151-159.
24. Pera M. Recent changes in the epidemiology of esophageal cancer. Surg Oncol 2001, 10:81-90.
25. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005, 54:710-717.
26. Lagergren J., Bergström R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999, 340:825-831.
27. Rubenstein J.H., Taylor J.B. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 2010, 32:1222-1227.
28. Bytzer P., Christensen P.B., Damkier P., et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999, 94:86-91.
29. Shalauta M.D., Saad R. Barrett's esophagus. Am Fam Physician 2004, 69:2113-2118.
30. Reynolds J.C., Waronker M., Pacquing M.S., et al. Barrett's esophagus: reducing the risk of progression to adenocarcinoma. Gastroenterol Clin North Am 1999, 28:917-945.
31. Hvid-Jensen F., Pedersen L., Drewes A.M., et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011, 365:1375-1383.
32. Wang Y., Beydoun M.A. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007, 29:6-28.
33. Hampel H., Abraham N.S., El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143:199-211.
34. Whiteman D.C., Sadeghi S., Pandeya N., et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008, 57:173-180.
35. Corley D.A., Kubo A., Levin T.R., et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterologist 2007, 133:34-41.
36. Gray M.R., Donnelly R.J., Kingsnorth A.N. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut 1993, 34:727-731.
37. Cook M.B., Kamangar F., Whiteman D.C., et al. Cigarette smoking and adenocarcinoma of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010, 102:1344-1353.
38. Anderson L.A., Cantwell M.M., Watson R.G., et al. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterologist 2009, 136:799-805.
39. Terry P., Lagergren J., Ye W., et al. Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterologist 2001, 120:387-391.
40. Mayne S.T., Risch H.A., Dubrow R., et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001, 10:1055-1062.
41. Kubo A., Levin T.R., Block G., et al. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol 2008, 103:1614-1623.
42. Iijima K., Grant J., McElroy K., et al. Novel mechanism of nitrosative stress from dietary nitrate with relevance to gastro-oesophageal junction cancers. Carcinogenesis 2003, 24:1951-1960.
43. Rokkas T., Pistiolas D., Sechopoulos P., et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007, 5:1413-1417.
44. Anderson L.A., Johnston B.T., Watson R.G., et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 2006, 66:4975-4982.
45. Heath E.I., Canto M.I., Piantadosi S., et al. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst 2007, 99:545-557.
46. Nguyen D.M., Richardson P., El-Serag H.B. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterologist 2010, 138:2260-2266.
47. Lagergren J., Bergström R., Adami H.O., et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000, 133:165-175.
48. Lanuti M., Liu G., Goodwin J.M., et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 2008, 14:3216-3222.
49. Chak A., Ochs-Balcom H., Falk G., et al. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 2006, 15:1668-1673.